Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.38EUR
−49.66 MEUR
12.32 MEUR
21.82 M
About scPharmaceuticals Inc.
Sector
CEO
John H. Tucker
Headquarters
Burlington
Website
Employees (FY)
136
Founded
2013
FIGI
BBG00KK7R6D0
scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2SX is 4.02 EUR — it has increased by 1.52% in the past 24 hours. Watch SCPHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange SCPHARMACEUTICALS INC stocks are traded under the ticker 2SX.
2SX stock has risen by 6.35% compared to the previous week, the month change is a 8.06% rise, over the last year SCPHARMACEUTICALS INC has showed a 55.33% decrease.
We've gathered analysts' opinions on SCPHARMACEUTICALS INC future price: according to them, 2SX price has a max estimate of 23.02 EUR and a min estimate of 14.73 EUR. Watch 2SX chart and read a more detailed SCPHARMACEUTICALS INC stock forecast: see what analysts think of SCPHARMACEUTICALS INC and suggest that you do with its stocks.
2SX stock is 1.50% volatile and has beta coefficient of 0.52. Track SCPHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is SCPHARMACEUTICALS INC there?
Today SCPHARMACEUTICALS INC has the market capitalization of 146.42 M, it has increased by 10.14% over the last week.
Yes, you can track SCPHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
SCPHARMACEUTICALS INC is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
2SX earnings for the last quarter are −0.33 EUR per share, whereas the estimation was −0.40 EUR resulting in a 17.56% surprise. The estimated earnings for the next quarter are −0.38 EUR per share. See more details about SCPHARMACEUTICALS INC earnings.
SCPHARMACEUTICALS INC revenue for the last quarter amounts to 5.66 M EUR, despite the estimated figure of 5.54 M EUR. In the next quarter, revenue is expected to reach 7.55 M EUR.
2SX net income for the last quarter is −13.08 M EUR, while the quarter before that showed −12.51 M EUR of net income which accounts for −4.49% change. Track more SCPHARMACEUTICALS INC financial stats to get the full picture.
No, 2SX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 1, 2024, the company has 136.00 employees. See our rating of the largest employees — is SCPHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SCPHARMACEUTICALS INC EBITDA is −54.80 M EUR, and current EBITDA margin is −402.93%. See more stats in SCPHARMACEUTICALS INC financial statements.
Like other stocks, 2SX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SCPHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SCPHARMACEUTICALS INC technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SCPHARMACEUTICALS INC stock shows the sell signal. See more of SCPHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.